Skip to main content

Table 2 TPT Cascade for PLHIV by Key Patient and Facility Variables, Namibia, 2014–2015

From: Evaluation of the uptake of tuberculosis preventative therapy for people living with HIV in Namibia: a multiple methods analysis

Patient/

Facility

Characteristic

Among patients eligible for TB screening, unweighted proportion screened for TB, weighted % (95% CI)

Among patients eligible for TB screening, unweighted proportion eligible for TPT, weighted % (95% CI)

Among patients eligible for TPT, unweighted proportion initiated TPT, weighted % (95% CI)

Among patients initiated TPT, unweighted proportion completed treatment, weighted % (95% CI)

Among patients eligible for TPT, unweighted proportion completed treatment, weighted % (95% CI)

Total

679/810,

87.1 (82.2–90.9)

646/810,

82.6 (76.8–87.2)

294/646,

45.4 (36.7–54.4)

139/294,

45.7 (32.0–60.0)

139/646,

20.7 (13.6–30.4) 54.4)45.7 (32.0–60.0

Sex

 Female

390/465,

86.6 (81.2–90.6)

375/465,

83.3 (77.0–87.9)

180/375,

48.2 (37.6–59.0)

89/180,

48.4 (34.2–62.8)

89/375,

23.3 (15.3–33.8)

 Male

237/287,

86.4 (78.8–91.5)

220/287,

79.8 (70.2–86.9)

92/220,

43.4 (33.3–54.0)

46/92,

47.2 (30.5–64.5)

46/220,

20.4 (12.2–32.1)

Age group (years)

 0–14

21/28,

83.0 (60.2–94.1)

21/28,

83.0 (60.2–94.1)

4/21,

19.1 (11.6–29.8)

2/4,

35.9 (5.1–85.4)

2/21,

6.8 (1.2–31.4)

 15–24

82/99,

91.4 (78.7–96.8)

79/99,

89.4 (76.9–95.6)

40/79,

48.4 (26.5–70.9)

20/40,

41.0 (23.8–60.6)

20/79,

19.8 (10.4–34.4)

 25+

491/577,

87.3 (82.3–91.1)

466/577,

82.4 (76.4–87.0)

225/466,

48.3 (40.4–56.4)

108/215,

47.2 (32.0–62.9)

108/466

22.8 (15.1–32.9)

Received Education on CTX/INH Prophylaxis

 Yes

205/237,

86.6 (79.4–91.6)

196/237,

83.0 (73.3–89.7)

95/196,

48.4 (36.1–60.9)

46/95,

44.2 (29.3–60.3)

46/196,

21.4 (13.4–32.5)

 No

192/213,

89.4 (81.4–94.2)

181/213,

84.0 (78.3–88.4)

91/181,

49.7 (40.3–59.1)

45/91,

50.1 (28.7–71.5)

45/181,

24.9 (14.9–38.6)

ART status

 On ART

555/597,

94.6 (90.9–96.9)a

524/597,

89.2 (84.0–92.8)b

245/524,

47.1 (38.2–56.2)

122/245,

47.7 (32.9–62.9)

122/524,

22.4 (14.7–32.6)

 Not on ART

93/155,

66.1 (47.2–81.0)

91/155,

63.8 (45.4–78.9)

38/91,

38.9 (27.6–51.6)

13/38,

31.8 (16.8–51.9)

13/91,

12.4 (5.2–26.5)

Current HIV Care and Treatment Facility

 Clinic

174/227,

78.7 (59.9–90.2)

171/227,

78.4 (59.3–90.0)

73/171,

50.2 (47.6–52.8)

34/73,

25.8 (11.3–48.6)

34/171,

12.9 (5.9–26.0)

 Health Center

134/162,

85.9 (78.3–91.1)

121/162,

75.7 (67.1–82.6)

60/121,

42.7 (28.9–57.7)

27/60,

37.5 (26.2–50.3)

27/121,

16.0 (10.2–24.2)

 Hospital

371/421,

87.9 (82.0–92.1)

354/421,

84.0 (77.4–88.9)

161/354,

45.4 (35.3–56.0)

78/161,

48.2 (32.0–64.8)

78/354,

21.9 (13.5–33.5)

  1. NOTE: all other bivariate associations were not statistically significant (p < 0.05)
  2. a (94.6% vs. 66.1%, p = < 0.01)
  3. b (89.2% vs. 63.8%, p = < 0.01)